Psychiatry
RCT | Group support and skill-based learning reduce opioid use in chronic pain, but leads to no effect on pain perception
29 May, 2023 | 11:14h | UTCReducing Opioid Use for Chronic Pain With a Group-Based Intervention: A Randomized Clinical Trial – JAMA (free for a limited period)
See also: Visual Abstract
News Release: New treatment helps people stop addictive opioid painkillers used for chronic pain – University of Warwick
SR | High-dose olanzapine in treatment-resistant schizophrenia
24 May, 2023 | 13:06h | UTC
Digital mental health: challenges and next steps
24 May, 2023 | 13:01h | UTCDigital mental health: challenges and next steps – BMJ Mental Health
RCT | Effectiveness of genotype-specific tricyclic antidepressant dosing in patients with major depressive disorder
23 May, 2023 | 12:52h | UTC
Commentary on Twitter
Genotype-guided tricyclic antidepressant dosing may help patients with depression reach faster therapeutic plasma concentrations, with potentially fewer adverse effects. https://t.co/06cIaQjmwV pic.twitter.com/ZBdXZLeWc3
— JAMA Network Open (@JAMANetworkOpen) May 8, 2023
M-A | Risk and benefits of wakefulness-promoting drugs in obstructive sleep apnea patients
23 May, 2023 | 12:43h | UTCComparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea: Systematic Review and Network Meta-analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Researchers find best treatment for excessive daytime sleepiness – McMaster University
M-A | Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia
23 May, 2023 | 12:39h | UTC
Drug-induced abnormal involuntary movements: prevalence and treatment
22 May, 2023 | 13:30h | UTC
Consensus Paper | Evidence-based consensus guidelines for the management of catatonia
16 May, 2023 | 14:50h | UTC
Commentary from the author on Twitter (thread – click for more)
📢Our new British Association for Psychopharmacology guidelines on CATATONIA are now out!📢
💠22 experts
💠3 continents
💠>500 referencesRead the full #OpenAccess guideline here: https://t.co/7w5b211JkQ.@BAPsych #catatonia pic.twitter.com/djuTKgv3Gz
— Jonathan Rogers (@drjprogers) April 11, 2023
RCT | Cognitive behavioral therapy proves effective for severe post-COVID-19 fatigue
15 May, 2023 | 13:16h | UTCNews Release: Cognitive behavioral therapy lessens post-viral fatigue after COVID-19 – Amsterdam UMC
Commentary on Twitter
Efficacy of Cognitive Behavioral Therapy Targeting Severe Fatigue Following COVID-19: Results of a Randomized Controlled Trial
✅ Just Accepted
🔓 Open Access@amsterdamUMChttps://t.co/P1jwLOcfvw— Clinical Infectious Diseases (@CIDJournal) May 13, 2023
Hoarding disorder: evidence and best practice in primary care
12 May, 2023 | 13:45h | UTCHoarding disorder: evidence and best practice in primary care – British Journal of General Practice
News Release: New guidance to help diagnose hoarding disorder – Anglia Ruskin University
RCT | Zuranolone outperforms placebo in major depressive disorder treatment
12 May, 2023 | 13:41h | UTCZuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo‐Controlled Phase 3 Trial – The American Journal of Psychiatry (link to abstract – $ for full-text)
Commentary: Zuranolone Found to Quickly Reduce Major Depression Symptoms in Phase 3 Trial – Psychiatric News Alert
Cohort Study | Association between cannabis use disorder and schizophrenia stronger in young males than in females
12 May, 2023 | 13:29h | UTCNews Release: Young men at highest risk of schizophrenia linked with cannabis use disorder – National Institutes of Health
Cohort Study | Association between depression and physical conditions requiring hospitalization
12 May, 2023 | 13:16h | UTCAssociation Between Depression and Physical Conditions Requiring Hospitalization – JAMA Psychiatry
Commentaries:
Study IDs Link for Depression, Physical Conditions Requiring Hospitalization – HealthDay
Commentary on Twitter
In this study, the main causes of excess hospitalizations in people with depression were endocrine, musculoskeletal, and vascular diseases. https://t.co/TNaVPKqEFE
— JAMA Psychiatry (@JAMAPsych) May 3, 2023
Autism spectrum disorders in adulthood: symptoms, diagnosis, and treatment
11 May, 2023 | 11:51h | UTC
RCT | Cognitive functional therapy with or without biofeedback outperforms usual care for chronic low back pain relief
10 May, 2023 | 15:58h | UTCCognitive functional therapy with or without movement sensor biofeedback versus usual care for chronic, disabling low back pain (RESTORE): a randomised, controlled, three-arm, parallel group, phase 3, clinical trial – The Lancet (link to abstract – $ for full-text)
News Release: Fresh hope for Australians living with chronic back pain – Curtin University
Guideline | Assessment and treatment of children and adolescents with major and persistent depressive disorders
10 May, 2023 | 15:37h | UTC
Review | Estimating risk of antidepressant withdrawal from a review of published data
9 May, 2023 | 14:39h | UTCEstimating Risk of Antidepressant Withdrawal from a Review of Published Data – CNS Drugs
Commentary: Researchers Identify Factors to Predict Risk of Antidepressant Withdrawal – Mad in America
Brief Review | Is combination pharmacotherapy effective for patients with acute depression?
8 May, 2023 | 12:57h | UTC
Examining impostor phenomenon through the lens of humility: spotlighting conceptual (dis)connections
3 May, 2023 | 14:56h | UTCExamining Impostor Phenomenon Through the Lens of Humility – Mayo Clinic Proceedings
Review | Suicide in young people: screening, risk assessment, and intervention
2 May, 2023 | 13:56h | UTCSuicide in young people: screening, risk assessment, and intervention – The BMJ
Cohort Study | Evaluation of brain-body health in individuals with common neuropsychiatric disorders
2 May, 2023 | 13:33h | UTCEvaluation of Brain-Body Health in Individuals With Common Neuropsychiatric Disorders – JAMA Psychiatry (link to abstract – $ for full-text)
Interview: Evaluation of Brain-Body Health in Individuals With Common Neuropsychiatric Disorders – JAMA
Commentary from the author on Twitter (thread – click for more)
Mental illness is a brain disorder? Right?
We thought so.
Hang on though, our new study @JAMAPsych shows that poor body health is a more pronounced manifestation of mental illness than poor brain health.https://t.co/4TFlt7awEY
🧵1/9 pic.twitter.com/92ZJAQWQlb
— Ye Ella Tian (@yetianmed) April 27, 2023
ASCO Guideline Update | Management of anxiety and depression in adult survivors of cancer
26 Apr, 2023 | 14:27h | UTCCommentary: ASCO Updates Guideline for Management of Anxiety and Depression in Adult Cancer Survivors – ASCO Daily News
Related: Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline – ESMO Open
Commentary on Twitter
Just issued: Guideline update on the management of anxiety and depression in adult #CancerSurvivors. Read more ➡️ https://t.co/gxv0I86jHX #survonc #supponc #psyonc pic.twitter.com/hwnNgTuqSo
— ASCO (@ASCO) April 20, 2023
ESMO Guideline | Anxiety and depression in adult cancer patients
26 Apr, 2023 | 14:26h | UTCAnxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline – ESMO Open
ADHD Medication Misuse | 25% of students in some US schools report nonmedical use for stimulant effect
26 Apr, 2023 | 14:21h | UTCNews Release: In some US schools, 1 in 4 students report misusing prescription stimulants – University of Michigan
Commentary on Twitter
Prescription stimulant misuse varies from 0% to >25% across US secondary schools. Schools with highest rates of stimulant therapy for #ADHD had 36% increased odds of misuse, offering targets for prevention and risk reduction strategies. https://t.co/4XHGpooBjz
— JAMA Network Open (@JAMANetworkOpen) April 18, 2023
Cohort Study | Prenatal exposure to antiseizure medication and incidence of childhood-onset psychiatric disorders
24 Apr, 2023 | 13:10h | UTCPrenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders – JAMA Neurology (link to abstract – $ for full-text)
Author Interview: Prenatal Exposure to Antiseizure Medication and Psychiatric Disorders – JAMA
Commentary on Twitter
Study strengthens the evidence for the warning against the use of valproate in pregnancy, supports concerns about the use of topiramate, and provides a preliminary indication for caution with the use of levetiracetam in pregnancy. https://t.co/BZzZP0tSZs
— JAMA Neurology (@JAMANeuro) April 17, 2023